Skip to main content
Caplight Logo









Tethis S.p.A.

Tethis S.p.A.

Private
MilanHealthcare & Life Scienceshttps://tethis-lab.com

Last Round

Early Funding

Jan 14, 2025

Total Funding Raised

$17.35M

Company Overview

Tethis S.p.A. is a biotechnology company that develops and commercializes a standardized liquid biopsy platform for cancer diagnostics and management.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

liquid biopsyliquid biopsy sample preppre-analytical automationcirculating tumor cellsCTCcell-free DNAcfDNAdiagnostic consumablesin-vitro diagnosticsIVDcancer diagnosticsrazor and blade modellab automationbiomarker analysispoint of collection prepnanocoated slides

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tethis S.p.A. Comparables

Compare Tethis S.p.A. with similar companies based on industry and business-model similarity.

Tethis S.p.A. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cell Microsystems
83%
nRichDX
80%
BioFluidica
79%

Tethis S.p.A. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJan 14, 2025
GrantMar 5, 2018
GrantJun 1, 2016
VC RoundJul 6, 2010

Key People

Founding team and executive leadership

Holger Neecke

Chief Executive Officer

Executive Team

Tethis S.p.A. Investors

Notable investors and investment history

Tethis S.p.A. investors
InvestorRounds
Indaco Venture Partners SGREarly Funding
ENEA-Tech and Biomedical FoundationEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 383% MoM.

  • Jan 14, 2025

    $15.4M raised in early funding.

Recent news

Latest coverage and updates

  • partners_withSep 21, 2026

    Tethis S.p.a. and Everex S.r.l. announced a long-term manufacturing and supply partnership in Italy on Sep 22nd '26, with Everex S.r.l. supporting production and future scale-up.

Tethis S.p.A. Filings

Explore SEC and related filing metadata, where available.

Tethis S.p.A. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Tethis S.p.A.'s valuation, stock price, and market status.

Is Tethis S.p.A. a public or private company?

Tethis S.p.A. is a private company.

What is the current stock price of Tethis S.p.A.?

Tethis S.p.A. is a private company, so its shares have no public market price. Caplight tracks Tethis S.p.A.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Tethis S.p.A. worth (valuation)?

Valuation information for Tethis S.p.A. is not publicly available.

Can I buy Tethis S.p.A. stock?

Tethis S.p.A. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Tethis S.p.A.'s last funding round?

Tethis S.p.A.'s most recent funding round was Early Funding on January 14, 2025.

Who are the main investors in Tethis S.p.A.?

Key investors in Tethis S.p.A. include ENEA-Tech and Biomedical Foundation.

Will Tethis S.p.A. IPO soon?

No public IPO plans have been announced for Tethis S.p.A..

How can I track Tethis S.p.A. secondary market activity?

Caplight tracks bids, offers, and trades in Tethis S.p.A.'s shares on secondary markets.

Firmographic Details

HeadquartersMilan
Employee Range32
Year Founded2004
Last FundingJan 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?